Ryusuke Koshida

606 total citations
18 papers, 444 citations indexed

About

Ryusuke Koshida is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Ryusuke Koshida has authored 18 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Ryusuke Koshida's work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (4 papers) and Pancreatic function and diabetes (4 papers). Ryusuke Koshida is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes Management and Research (4 papers) and Pancreatic function and diabetes (4 papers). Ryusuke Koshida collaborates with scholars based in Japan, United Kingdom and Mexico. Ryusuke Koshida's co-authors include Satoru Takahashi, Minako Ito, Rimpei Morita, Tatsuhiko Kodama, Hiroaki Ooboshi, Takashi Shichita, Kyoko Komai, Akihiko Yoshimura, Yoshiko Noguchi and Hisashi Oishi and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Ryusuke Koshida

18 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryusuke Koshida Japan 9 170 127 121 58 52 18 444
Wanchao Ma United States 9 253 1.5× 72 0.6× 78 0.6× 22 0.4× 29 0.6× 13 678
Gaetano Desina Italy 8 213 1.3× 141 1.1× 48 0.4× 80 1.4× 26 0.5× 10 502
Alexander Widiapradja Australia 12 186 1.1× 176 1.4× 106 0.9× 50 0.9× 32 0.6× 17 569
Justin Lengfeld United States 10 186 1.1× 76 0.6× 80 0.7× 102 1.8× 156 3.0× 12 558
Xiangguo Dai United States 11 172 1.0× 77 0.6× 59 0.5× 62 1.1× 27 0.5× 14 501
Chao Gan China 14 145 0.9× 54 0.4× 49 0.4× 30 0.5× 35 0.7× 27 415
Michael A Hagler United States 6 293 1.7× 185 1.5× 42 0.3× 63 1.1× 69 1.3× 20 813
Cristina Sastre United States 12 126 0.7× 121 1.0× 26 0.2× 48 0.8× 32 0.6× 17 349
Meike Schaub Germany 10 73 0.4× 153 1.2× 62 0.5× 123 2.1× 33 0.6× 17 493
Maki Kabara Japan 13 177 1.0× 46 0.4× 28 0.2× 53 0.9× 65 1.3× 28 400

Countries citing papers authored by Ryusuke Koshida

Since Specialization
Citations

This map shows the geographic impact of Ryusuke Koshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryusuke Koshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryusuke Koshida more than expected).

Fields of papers citing papers by Ryusuke Koshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryusuke Koshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryusuke Koshida. The network helps show where Ryusuke Koshida may publish in the future.

Co-authorship network of co-authors of Ryusuke Koshida

This figure shows the co-authorship network connecting the top 25 collaborators of Ryusuke Koshida. A scholar is included among the top collaborators of Ryusuke Koshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryusuke Koshida. Ryusuke Koshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Harada‐Shiba, Mariko, Junya Ako, Atsushi Hirayama, et al.. (2021). Familial Hypercholesterolemia in Patients with Acute Coronary Syndrome: Genetic Insights from EXPLORE-J. Journal of Atherosclerosis and Thrombosis. 29(8). 1201–1212. 6 indexed citations
2.
Hirose, Takahisa, Masato Odawara, Munehide Matsuhisa, et al.. (2020). Risk of hypoglycemia in Japanese people with type 2 diabetes mellitus who initiated or switched to insulin glargine 300 U/mL: A subgroup analysis of 12-month post-marketing surveillance study (X-STAR study). Diabetes Research and Clinical Practice. 172. 108647–108647. 2 indexed citations
5.
Odawara, Masato, Munehide Matsuhisa, Takahisa Hirose, et al.. (2020). Effectiveness and safety of insulin glargine 300 unit/mL in Japanese type 2 diabetes mellitus patients: a 12-month post-marketing surveillance study (X-STAR study). Expert Opinion on Pharmacotherapy. 21(14). 1771–1780. 2 indexed citations
6.
Matsuhisa, Munehide, Masato Odawara, Takahisa Hirose, et al.. (2020). Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study). Expert Opinion on Pharmacotherapy. 22(2). 249–256. 1 indexed citations
8.
Nogami, Haruo, et al.. (2019). Inhibition of epidermal growth factor receptor stimulates prolactin expression in primary culture of the mouse pituitary gland. Journal of Neuroendocrinology. 31(8). e12764–e12764. 1 indexed citations
9.
Koshida, Ryusuke, et al.. (2019). Neuron-specific <i>Mafb</i> knockout causes growth retardation accompanied by an impaired growth hormone/insulin-like growth factor I axis. EXPERIMENTAL ANIMALS. 68(4). 435–442. 2 indexed citations
10.
Koshida, Ryusuke, et al.. (2018). Myosin Id localizes in dendritic spines through the tail homology 1 domain. Experimental Cell Research. 367(1). 65–72. 1 indexed citations
11.
Tran, Mai T., Michito Hamada, Hyojung Jeon, et al.. (2017). MafB is a critical regulator of complement component C1q. Nature Communications. 8(1). 1700–1700. 66 indexed citations
12.
Shichita, Takashi, Minako Ito, Rimpei Morita, et al.. (2017). MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Nature Medicine. 23(6). 723–732. 187 indexed citations
13.
Morito, Naoki, Keigyou Yoh, Hisashi Oishi, et al.. (2017). Transcription factor MafB may play an important role in secondary hyperparathyroidism. Kidney International. 93(1). 54–68. 17 indexed citations
14.
Koshida, Ryusuke, Hisashi Oishi, Michito Hamada, Yosuke Takei, & Satoru Takahashi. (2016). MafB is required for development of the hindbrain choroid plexus. Biochemical and Biophysical Research Communications. 483(1). 288–293. 5 indexed citations
15.
Koshida, Ryusuke, Hisashi Oishi, Michito Hamada, & Satoru Takahashi. (2015). MafB antagonizes phenotypic alteration induced by GM-CSF in microglia. Biochemical and Biophysical Research Communications. 463(1-2). 109–115. 15 indexed citations
16.
Oishi, Hisashi, Yukari Sekiguchi, Ryusuke Koshida, et al.. (2014). Generation of Insulin-Producing Cells from the Mouse Liver Using β Cell-Related Gene Transfer Including Mafa and Mafb. PLoS ONE. 9(11). e113022–e113022. 15 indexed citations
17.
Yanagi, Shigehisa, Kohichi Kawahara, Miki Nishio, et al.. (2012). Epithelial Pten Controls Acute Lung Injury and Fibrosis by Regulating Alveolar Epithelial Cell Integrity. American Journal of Respiratory and Critical Care Medicine. 187(3). 262–275. 70 indexed citations
18.
Koshida, Ryusuke, et al.. (2010). A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets. Journal of Bone and Mineral Metabolism. 28(5). 585–590. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026